DK0730465T3 - Anvendelse af angiotensin III og analoger dertil til vævsreparation - Google Patents

Anvendelse af angiotensin III og analoger dertil til vævsreparation

Info

Publication number: DK0730465T3
Authority: DK; Denmark
Prior art keywords: analogues; angiotensin iii; tissue repair; wound healing; analogs
Prior art date: 1993-09-24

Application number

DK94928150T

Other languages

English (en)

Inventor

Gere Stodder Dizerega

Kathleen Elizabeth Rodgers

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-24

Filing date

1994-09-19

Publication date

2002-04-08

1994-09-19 Application filed by Univ Southern California filed Critical Univ Southern California

2002-04-08 Application granted granted Critical

2002-04-08 Publication of DK0730465T3 publication Critical patent/DK0730465T3/da

Links

QMMRCKSBBNJCMR-KMZPNFOHSA-N Angiotensin III Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCN=C(N)N)C(C)C)C1=CC=C(O)C=C1 QMMRCKSBBNJCMR-KMZPNFOHSA-N 0.000 title abstract 2
101800000738 Angiotensin-3 Proteins 0.000 title abstract 2
102400000348 Angiotensin-3 Human genes 0.000 title abstract 2
230000017423 tissue regeneration Effects 0.000 title 1
230000029663 wound healing Effects 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
239000013543 active substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Surgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

DK94928150T 1993-09-24 1994-09-19 Anvendelse af angiotensin III og analoger dertil til vævsreparation DK0730465T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US12636893A	1993-09-24	1993-09-24
PCT/US1994/010503 WO1995008337A1 (en)	1993-09-24	1994-09-19	Use of angiotensin iii and analogs thereof in tissue repair

Publications (1)

Publication Number	Publication Date
DK0730465T3 true DK0730465T3 (da)	2002-04-08

Family

ID=22424455

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94928150T DK0730465T3 (da)	1993-09-24	1994-09-19	Anvendelse af angiotensin III og analoger dertil til vævsreparation

Country Status (13)

Country	Link
US (1)	US5629292A (da)
EP (1)	EP0730465B1 (da)
JP (1)	JPH09502977A (da)
AT (1)	ATE210677T1 (da)
AU (1)	AU706333B2 (da)
CA (1)	CA2172493C (da)
DE (1)	DE69429450T2 (da)
DK (1)	DK0730465T3 (da)
ES (1)	ES2168312T3 (da)
PT (1)	PT730465E (da)
TW (1)	TW311088B (da)
WO (1)	WO1995008337A1 (da)
ZA (1)	ZA947338B (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5955430A (en) *	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) *	1994-11-14	2003-03-20	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
MY121607A (en) *	1995-07-10	2006-02-28	Hyundai Curitel Inc	Grid moving method of object image and apparatus using the same and compaction/motion estimation method using the same and apparatus thereof
US6110895A (en) *	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
US6335195B1 (en) *	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
EP1410801B1 (en)	1997-01-28	2013-04-10	University Of Southern California	Method for promoting hematopoietic cell proliferation and differentiation
AU6650098A (en) *	1997-02-04	1998-08-25	University Of Southern California	Method for accelerating healing of thermal injuries
US6197751B1 (en)	1997-11-10	2001-03-06	The United States Of America As Represented By The Department Of Health And Human Services	Thymosin α1 promotes tissue repair, angiogenesis and cell migration
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
AU1706399A (en) *	1997-11-26	1999-06-15	University Of Southern California	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
AU755225B2 (en)	1997-12-12	2002-12-05	University Of Southern California	Wound healing compositions
WO1999040106A2 (en) *	1998-02-09	1999-08-12	University Of Southern California	Use of angiotensin analogues for promoting erythropoiesis
US7173011B2 (en)	2000-11-20	2007-02-06	University Of Southern California	Radiation therapy methods
US6455500B1 (en)	1998-03-10	2002-09-24	University Of Southern California	Radiation therapy methods
AU3077299A (en)	1998-03-11	1999-09-27	University Of Southern California	Method of promoting production of living tissue equivalents
AU752041B2 (en) *	1998-04-09	2002-09-05	University Of Southern California	Methods for treatment and prevention of infections
US6762167B1 (en)	1998-05-11	2004-07-13	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6475988B1 (en)	1998-05-11	2002-11-05	University Of Southern California	Methods to increase white blood cell survival after chemotherapy
US6916783B2 (en)	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
JP3686335B2 (ja)	1998-07-13	2005-08-24	ユニヴァースティオブサザーンカリフォルニア	骨および軟骨成長と修復を促進する方法
AU755943B2 (en) *	1998-08-13	2003-01-02	University Of Southern California	Methods to increase blood flow to ischemic tissue
PT1035133E (pt)	1999-02-17	2005-05-31	Pfizer Prod Inc	Proteinas de fusao compreendendo veiculos que podem induzir uma dupla resposta imune
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US7338938B2 (en)	1999-05-10	2008-03-04	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6821953B1 (en)	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
ATE474572T1 (de) *	2000-11-30	2010-08-15	Novodermix Internat Ltd	Heilung von wunden
WO2002087504A2 (en) *	2001-05-01	2002-11-07	University Of Southern California	Methods for inhibiting tumor cell proliferation
WO2009033820A2 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
RU2010113992A (ru) *	2007-09-11	2011-10-20	Мондобайотек Лабораториз Аг (Li)	Применение урокортина и кортиколиберина в качестве терапевтических средств
CA2699100A1 (en) *	2007-09-11	2009-04-02	Dorian Bevec	Use of a peptide as a therapeutic agent
EP2197463A2 (en) *	2007-09-11	2010-06-23	Mondobiotech Laboratories AG	Use of rgdspasskp and optionally angiotensin ii as therapeutic agents in the treatment of eg s. pneumoniae infections
CA2699177A1 (en) *	2007-09-11	2009-04-02	Mondobiotech Laboratories Ag	Use of a peptide as a therapeutic agent
WO2009114461A2 (en) *	2008-03-10	2009-09-17	University Of Southern California	Angiotensin (1-7) dosage forms and uses thereof
JP5647146B2 (ja)	2008-12-29	2014-12-24	トレベナ・インコーポレイテッドＴｒｅｖｅｎａ，Ｉｎｃ．	β−アレスチンエフェクターおよび組成物およびその使用方法
MX2012010783A (es)	2011-02-02	2012-11-23	Univ Southern California	Metodos para tratar ulceras del pie diabetico.
EP2809337A4 (en)	2012-01-31	2016-05-11	Trevena Inc	SS ARRESTINE EFFECTORS AND COMPOSITIONS AND METHOD FOR THE APPLICATION THEREOF
US8557958B1 (en)	2012-06-18	2013-10-15	Tarix Pharmaceuticals Ltd.	Compositions and methods for treatment of diabetes
US8633158B1 (en)	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
WO2015002903A1 (en)	2013-07-03	2015-01-08	Arizona Board Of Regents For The University Of Arizona	Method for treating cognitive dysfunction
JP2017506235A (ja)	2014-02-07	2017-03-02	トレベナ・インコーポレイテッドＴｒｅｖｅｎａ，Ｉｎｃ．	ベータ−アレスチンエフェクターの結晶性および非晶質形態
US9333233B2 (en)	2014-02-25	2016-05-10	Tarix Pharmaceuticals Ltd.	Methods and compositions for the delayed treatment of stroke
CA2948858A1 (en)	2014-05-19	2015-11-26	Trevena, Inc.	Synthesis of beta-arrestin effectors
US10183055B2 (en)	2014-07-21	2019-01-22	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
JP6666899B2 (ja)	2014-07-21	2020-03-18	アリゾナボードオブリージェンツオンビハーフオブザユニヴァーシティーオブアリゾナ	Ａｎｇ−（１−７）誘導体オリゴペプチド、ならびにそれを使用および作製するための方法
JP2018530590A (ja) *	2015-10-14	2018-10-18	タリックスファーマシューティカルズリミテッド	表皮水疱症の処置のための方法及び組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3886134A (en) *	1970-03-09	1975-05-27	Morton Norwich Products Inc	Analogues of angiotensin II
US5015629A (en) *	1989-06-26	1991-05-14	University Of Southern California	Tissue repair

1994
- 1994-09-19 DK DK94928150T patent/DK0730465T3/da active
- 1994-09-19 JP JP7509853A patent/JPH09502977A/ja not_active Ceased
- 1994-09-19 ES ES94928150T patent/ES2168312T3/es not_active Expired - Lifetime
- 1994-09-19 CA CA002172493A patent/CA2172493C/en not_active Expired - Lifetime
- 1994-09-19 AT AT94928150T patent/ATE210677T1/de not_active IP Right Cessation
- 1994-09-19 DE DE69429450T patent/DE69429450T2/de not_active Expired - Fee Related
- 1994-09-19 PT PT94928150T patent/PT730465E/pt unknown
- 1994-09-19 AU AU77302/94A patent/AU706333B2/en not_active Ceased
- 1994-09-19 EP EP94928150A patent/EP0730465B1/en not_active Expired - Lifetime
- 1994-09-19 WO PCT/US1994/010503 patent/WO1995008337A1/en not_active Ceased
- 1994-09-21 ZA ZA947338A patent/ZA947338B/xx unknown
- 1994-11-05 TW TW083110297A patent/TW311088B/zh active
- 1994-11-14 US US08/337,781 patent/US5629292A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO1995008337A1 (en)	1995-03-30
US5629292A (en)	1997-05-13
TW311088B (da)	1997-07-21
ATE210677T1 (de)	2001-12-15
AU706333B2 (en)	1999-06-17
EP0730465A1 (en)	1996-09-11
ES2168312T3 (es)	2002-06-16
EP0730465B1 (en)	2001-12-12
EP0730465A4 (en)	1997-11-12
AU7730294A (en)	1995-04-10
DE69429450T2 (de)	2002-07-25
CA2172493C (en)	2003-09-16
DE69429450D1 (de)	2002-01-24
JPH09502977A (ja)	1997-03-25
PT730465E (pt)	2002-06-28
CA2172493A1 (en)	1995-03-30
ZA947338B (en)	1995-05-10

Publication	Publication Date	Title
DK0730465T3 (da)	2002-04-08	Anvendelse af angiotensin III og analoger dertil til vævsreparation
MX9703609A (es)	1997-08-30	Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
DE69435301D1 (de)	2010-08-26	Verwendung von Angiotensin-II-Analogen zur Gewebewiederherstellung
DE69824445D1 (de)	2004-07-15	Zusammensetzungen zur wundheilung
ES2133807T3 (es)	1999-09-16	Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas.
ES2154650T3 (es)	2001-04-16	Composicion que comprende una formulacion con factor de coagulacion viii, procedimiento para su preparacion y uso de un tensioactivo como estabilizador.
DK0785948T3 (da)	2003-08-04	Analoger af keratinocyt vækstfaktor
DK0759687T3 (da)	1999-05-17	Anvendelse af gelpræparater som bejdsemidler
NO991302D0 (no)	1999-03-17	Munnvask-sammensetninger
ATE423562T1 (de)	2009-03-15	Alpha-ketoamidhaltige multikatalytische protease inhibitoren
DE60040753D1 (de)	2008-12-18	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
DK0888323T3 (da)	2004-08-09	Dihydrobenzofuran og beslægtede forbindelser, der er nyttige som antiinflammatoriske midler
BR0111678A (pt)	2003-06-03	Composições medicinais contendo derivados de propenona
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
ATE172108T1 (de)	1998-10-15	Verwendung von diglycerinestern gegen unreine haut
ES2134237T3 (es)	1999-10-01	Composiciones farmaceuticas que contienen acido ursodesoxicolico.
ES2088128T3 (es)	1996-08-01	Aminosulfonilureas inhibidoras de acat.
PT1089625E (pt)	2003-04-30	Agentes ectoparasiticidas
NO985679D0 (no)	1998-12-04	Dihydrobenzopyran og beslektede forbindelser nyttige som anti-inflammasjonsmidler
BR9611472A (pt)	1999-02-02	Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
UY26514A1 (es)	2001-07-31	" composición para el tratamiento de tejidos danados".
ES2121109T3 (es)	1998-11-16	Composicion de champu.
NO20022000L (no)	2002-06-27	6-metoksy-2-naftyleddiksyre-prodrogesammensetninger til behandling av inflammasjon
MX9709983A (es)	1998-03-29	El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
IT1265647B1 (it)	1996-11-22	Composizione farmaceutiche topiche per le allergie respiratorie